aod9604 effect on igf-1 levels study AOD 9604: Peptide Claims vs Clinical Reality AOD 9604 is marketed as a fat-metabolism peptide derived from a growth hormone Peptide Therapy Weight Loss in

Route Of Administration Oral (capsules, tablets), Subcutaneous (SC) injection

NNMT is an enzyme that catalyzes the transfer of a methyl group from S-adenosylmethionine (SAM) to nicotinamide (NAM), producing 1-methylnicotinamide (MNA) and S-adenosylhomocysteine (SAH)

Tracked claims Free report Get the source-quality checklist Use the same checklist Peptide Report uses to separate AOD-9604 claims, source records, supplier documentation, and media signals

The copper gives the reconstituted solution its characteristic clear-blue color

Reported side effects are generally mild and may include: Injection site reactions (redness, swelling) Temporary water retention Headaches (typically mild and transient) Nausea (rare and usually dose-related) Comparison to other peptides Unlike growth hormone secretagogues like MK-677 or CJC-1295, AOD 9604 doesnt stimulate natural HGH production